Yet another explanation why HR+/HER2- breast cancer does not respond well to immune checkpoint inhibitors.
#cancer #oncology #pembrolizumab #esr1
pubmed.ncbi.nlm.nih.gov/40956534/
New data from VERITAC-2:
@erikahamilton9.bsky.social
discusses how the oral PROTAC degrader vepdegestrant stacks up against fulvestrant in ESR1-mutated, ER+/HER2– metastatic breast cancer. Watch the interview: docwirenews.com/post/dr-erik... #ASCO25 #BreastCancer #ESR1 #bcsm @scri.com
@ASCO
Early camizestrant therapy keeps advanced breast cancer in check www.news-medical.net/news/2025060... #breastcancer #oncology #camizestrant #SERD #ESR1 #clinicaltrial @nejm.org
Are serial liquid biopsies finally ready for prime time?
If #camizestrant is approved based on #SERENA-6, it would mark the first therapy triggered by a rising #ESR1 mutation before visible recurrence.
That means #ctDNA won’t just monitor—it could guide treatment.
@ascocancer.bsky.social
#bcsm
SciTech Chronicles. . . . . . . . .Mar 17th, 2025
bit.ly/stc031725
#dementia #nitrate #Porphyromonas #Neisseria #Lookup #Registration #IETF #gTLD #MIMO #FPA #MRA #SQP #wildfires #mesh #Kinéis #Silvanet #cortical #amygdala #neurobiology #ESR1
#EMBER3 takeaways:
imlunestrant 🔼 PFS in patients with #ESR1 mut #MBC (5.5 vs. 3.8 mo)
Combination with abemaciclib further 🔼 PFS regardless of ESR1 and PIK3CA #ctDNA status (9.4 vs. 5.5 mo)
Previous CDK4/6i were mainly Palbo and Ribo in the MBC setting
#SABCS24 #bcsm #BreastCancer
Bio-Techne Introduces Advanced ESR1 Mutation Monitoring Assay for Breast Cancer Treatment Insights #United_States #Minneapolis #Bio-Techne #ESR1 #Asuragen